Your browser doesn't support javascript.
loading
Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays.
Morice, Pierre-Marie; Coquan, Elodie; Weiswald, Louis-Bastien; Lambert, Bernard; Vaur, Dominique; Poulain, Laurent.
Afiliação
  • Morice PM; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Team (Biology and Innovative Therapeutics for Ovarian Cancers), Caen, France.
  • Coquan E; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.
  • Weiswald LB; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Team (Biology and Innovative Therapeutics for Ovarian Cancers), Caen, France.
  • Lambert B; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.
  • Vaur D; UNICANCER, Department of Medical Oncology, Comprehensive Cancer Center François Baclesse, Caen, France.
  • Poulain L; UNICANCER, Department of Clinical Research, Comprehensive Cancer Center François Baclesse, Caen, France.
Br J Cancer ; 125(1): 7-14, 2021 07.
Article em En | MEDLINE | ID: mdl-33767416
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organoides / Análise de Sequência de DNA / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organoides / Análise de Sequência de DNA / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article